ADDF’s Fillit On FDA’s Tough Aducanumab Decision, Advances In Alzheimer’s

New Blood Test Should Aid Drug Trials, Symptomatic Treatments Advancing

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.